tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market
MYGN
Myriad Genetics
RESEARCH TOOLSreports
Want to see MYGN full AI Analyst Report?

Myriad Genetics (MYGN) Income Statement

429 Followers

Myriad Genetics Income Statement

Last quarter (Q4 2025), Myriad Genetics's total revenue was $209.80M, a decrease of -0.38% from the same quarter last year. In Q4, Myriad Genetics's net income was $-7.90M. See Myriad Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 824.50M$ 837.60M$ 753.20M$ 678.40M$ 690.60M
Gross Profit
$ 576.60M$ 585.40M$ 517.00M$ 476.40M$ 493.00M
Operating Expenses
$ 715.90M$ 708.90M$ 774.40M$ 617.00M$ 683.50M
Depreciation and Amortization
$ -14.40M$ 61.20M$ 61.90M$ 52.70M$ 62.80M
EBITDA
$ -397.40M$ -59.50M$ -197.40M$ -84.70M$ 12.30M
Operating Income
$ -139.30M$ -123.50M$ -257.40M$ -140.60M$ -190.50M
Other Income/Expenses
$ -255.80M$ 0.00$ -4.80M$ 0.00$ 133.40M
Pretax Income
$ -395.10M$ -123.50M$ -262.20M$ -140.60M$ -57.10M
Net Income
$ -365.90M$ -127.30M$ -263.30M$ -112.00M$ -27.20M
Per Share Metrics
Basic EPS
$ -3.96$ -1.41$ -3.18$ -1.39$ -0.35
Diluted EPS
$ -3.96$ -1.41$ -3.18$ -1.39$ -0.35
Weighted Average Shares Outstanding
 93.30M 90.60M 82.80M 80.58M 77.71M
Weighted Average Shares Outstanding (Diluted)
 93.30M 90.60M 82.80M 80.60M 78.00M
Currency in USD

Myriad Genetics Earnings and Revenue History